Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

Similar documents
Partial Table of Contents (Contact Client Services to receive complete Table of Contents) IV. Design Criteria for Decentralized Testing Products

Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests. List of Tables

New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape.

New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape. Table of Contents

New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape.

New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape.

New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape.

Table of Contents. III. Major Current And Emerging Cancer Diagnostic Tests

TUMOR MARKERS: US, EUROPE, JAPAN Emerging Opportunities And Business Expansion Strategies. Table of Contents

2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices. Table of Contents

CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS Emerging Assays, and Companies Developing New Technologies and Products.

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

MARTIN FLEISHER, PH.D., FACB MEMORIAL SLOAN-KETTERING CANCER CENTER NEW YORK, N.Y.

Global Hepatitis B and C Diagnostics Market

Global Irritable Bowel Syndrome (IBS) Market: Trends & Opportunities ( )

RENAL BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

In Situ Hybridization: Market Strategies and Forecasts, US,

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

PRODUCT LIST 2018 Immunoassays RIA, IRMA, REA

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

Tumor Markers & Cytopathology

PRODUCT LIST 2011 Immunoassays RIA, IRMA, REA

Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes

TUMOR M ARKERS MARKERS

REFERENCE CODE GDME1053CFR PUBLICAT ION DATE AUGUST 2013 IN-VITRO COLORECTAL CANCER SCREENING TESTS - US ANALYSIS AND MARKET FORECASTS

GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES

IMMUNOASSAY PREMIUM - LEVEL 3 (IA PREMIUM 3)

Types of target values, acceptable ranges

GLOBAL GENETIC TESTING MARKET. Growth Trends & Forecasts. mordorintelligence.com

Fast, automated, precise

Oligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research

LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS

CHAPTER ONE: EXECUTIVE SUMMARY

Taking Laboratory Coding for a Spin. Corrie Alvarez, CPC, CPMA, CPC-I, CEDC

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Hypodermic Needles Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to Hexa Research

November 2012 Volume: TMRCHPV CYTOLOGY AND HPV TESTING WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)

SCPA607 Biological markers for cancer diagnosis

Thermo Scientific B R A H M S Biomarkers Tumor Marker Assays. Excellent precision. Confident cancer monitoring

PRODUCT I N FOR MATION Fujirebio Diagnostics EIA Kit

REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013

REFERENCE CODE GDHC465DFR PUBLICAT ION DATE SEPTEMBER 2014 KADCYLA (HER2-POSITIVE BREAST CANCER) - FORECAST AND MARKET ANALYSIS TO 2023

Jefferies Healthcare Conference. John Bishop Chairman & CEO June 2, 2014

DiaSorin Group Company Presentation. March 2019

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

Tumor Markers. Units: U/ml Ref.- range: <35.0

Commentary by R. Little, Ph.D., NGSP Network Coordinator for the NGSP Steering Committee

ph Meters Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

REFERENCE CODE GDHC476DFR PUBLICAT ION DATE NOVEMBER 2014 CYRAMZA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

Pancreatic Cancer Market Research Report- Global Forecast till 2023

REFERENCE CODE GDHCER046 PUBLICAT ION DATE OCTOBER 2013 DIABETIC FOOT ULCERS - EPIDEMIOLOGY FORECAST TO 2022

CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Size and Growth of the Market Test Segments Geographic Distribution Market Trends

Bead Chemiluminescense IMMULITE 2000, 2000 XPI & 2500

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )

Appendix H 2018 FCDS Required Site Specific Data Items (SSDIs)

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Roche Diagnostics Daniel O Day COO Roche Diagnostics. Société Générale - The Premium Review Conference, Paris December 2, 2011

CERTIFICATE OF ACCREDITATION

Immunoassay. Product Portfolio. Part of the IDS group

View Report Details. Global Coronary Stent Market

IMMUNOASSAY PREMIUM PLUS - LEVEL 2 (IA PREMIUM PLUS 2)

CERTIFICATE OF ACCREDITATION

Dr.R.Venkateswari Assistant Professor Department of Medical Biochemistry University of Madras, Taramani Campus, Chennai

Diagnostics Division. Daniel O Day COO Roche Diagnostics

Analysis of European Medical Food Ingredients Market

Tumor Markers. Units: U/ml Ref.- range: <35.0

PRODUCT INFORMATION Fujirebio Diagnostics EIA Kit

We Innovate for Life John Bishop Chairman and Chief Executive Officer June 2016

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

Analysis of the U.S. Medical Computed Tomography Imaging Systems Market

Europe Ginseng Market Report 2016

REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

Bihong Zhao, M.D, Ph.D Department of Pathology

REFERENCE CODE GDHC422DFR PUBLICAT ION DATE M AY 2014 BRINTELLIX (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

1. Purpose 1.1. To define testing locations, schedule and order priority for each test performed in the core laboratory.

Analyte Specimen Demographic Reference Range Units

REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

Biomarkers in drug discovery and development. Margit Wissenbach, PhD Dir Business Development Scandinavia

LUPUZOR (SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS) - FORECAST AND MARKET ANALYSIS TO 2022

J.P. Morgan. 27 th Annual Healthcare Conference. San Francisco January 14 th, 2009

REFERENCE CODE GDHC426DFR PUBLICAT ION DATE M AY 2014 CARIPRAZINE (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

MARCH 2017 RESEARCH REPORT

REFERENCE CODE GDHCER043 PUBLICAT ION DATE NOVEMBER 2013 PARKINSON S DISEASE - EPIDEMIOLOGY FORECAST TO 2022

REFERENCE CODE GDHC425DFR PUBLICAT ION DATE M AY 2014 BREXPIPRAZOLE (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

THYROID HORMONE THERAPY TABLE 21 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR FIGURE 4 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

THYROID TUMOR DIAGNOSIS: MARKER OF THE MONTH CLUB

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

CHAPTER FOUR: MARKET SIZE AND GROWTH SLEEP MEDICATIONS MARKET PRESCRIPTION... 40

Global Oil Softgel Capsules Market Research Report 2016

Transcription:

Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Bichemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices Partial Table of Contents (Contact Client Services to receive complete Table of Contents) I. Introduction II. Worldwide Market Overview A. Market Overview B. Worldwide Market Structure C. Worldwide Market Size and Growth III. Major Product Development Opportunities A. Reagent Kits and Test Systems/Panels B. Instrumentation C. Computers, Software and Automation D. Auxiliary Products IV. Design Criteria for Decentralized Testing Products V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Worldwide Market and Technology Overview A. Major Current and Emerging Cancer Diagnostic Tests 1. Biochemical Tumor Markers 2. Oncogenes 3. Polypeptide Growth Factors 4. Ectopic Hormones 5. Colony Stimulating Factors 6. Lymphokines 7. Immunohistochemical Stains 8. Emerging Tumor Markers

Table of Contents B. Instrumentation Review and Market Needs C. Current and Emerging Technologies D. Personal Testing VIII. Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Dynamics, Trends, Size and Growth - Volume Forecasts by Test and Market Segment - Sales Forecasts by Test and Market Segment - Major Supplier Sales and Market Shares IX. Competitive Profiles - Abbott - AdnaGen - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - biomerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group

Table of Contents - Epigenomics - Enterix - Enzo Biochem - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic/Gen-Probe - Kreatech/Leica - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Quest Diagnostics - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Thermo Fisher - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila X. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

Cancer Diagnostic Classification ACTH Tests AFP Tests Beta-2 Microglobulin Tests CA 15-3/27.29 Tests CA 19-9 Tests CA 125 Tests Calcitonin Tests CEA Tests Estrogen Receptor Tests Progesterone Receptor Tests Ferritin Tests Gastrin Tests

HCG Tests Insulin Tests NSE Tests Occult Blood Tests PAP Smear/HPV Tests PAP Tests PSA Tests Lymphocyte Subclassification Tests Biochemical Markers Potential Applications In Cancer Diagnosis Oncogenes Potential Applications In Cancer Diagnosis Oncogene Tests Growth Factors Potential Applications In Cancer Diagnosis Colony Stimulating Factors Potential Applications in Cancer Diagnosis Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential Applications in Cancer Diagnosis Executive Summary Table: Germany, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment Germany, Estimated Cancer Death Rates Germany, Laboratories Performing Cancer Diagnostic Tests by Market Segment Germany, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size Germany, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume Germany, Total Cancer Diagnostic Test Volume Forecasts by Market Segment Germany, All Market Segments, Major Cancer Diagnostic Test Volume Forecasts by Test Germany, Hospital Laboratories, Major Cancer Diagnostic Test Volume Forecasts by Test Germany, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts Germany, Total Cancer Diagnostic Sales Forecasts by Market Segment

Germany, All Market Segments Major Tumor Marker Sales Forecasts by Test Germany, Hospital Laboratories, Major Tumor Marker Sales Forecasts by Test Germany, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test Germany, Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test Germany, ACTH Test Volume and Diagnostics Germany, AFP Test Volume and Diagnostics Germany, Beta-2 Microglobulin Test Volume And Germany, CA-15-3/27.29 Test Volume and Germany, CA-19 Test Volume and Diagnostics Germany, CA 125 Test Volume and Diagnostics Germany, Calcitonin Test Volume And Diagnostic Germany, Cathepsin Test Volume and Diagnostics Germany, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment

Germany, Chromogranin Test Volume And Germany, Colon-Specific Antigen Test Volume And Germany, Cytokeratins Test Volume and Germany, Estrogen Receptor Test Volume and Germany, Ferritin Test Volume and Diagnostics Germany, Gastrin Test Volume and Diagnostics Germany, HCG, Test Volume and Diagnostics Germany, Insulin Test Volume and Diagnostics Germany, Interferons Test Volume and Germany, Interleukins Test Volume and Germany, Lymphocyte Subtyping Test Volume and Germany, NSE Test Volume and Diagnostics Germany, Occult Blood Test Volume and

Germany, Oncogenes Test Volume and Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment Germany, Pap Smear Test Volume and Germany, Parathyroid Hormone Test Volume and Germany, Progesterone Receptor Test Volume And Germany, PAP Test Volume and Diagnostics Germany, PSA Test Volume and Diagnostics Germany, S-100 Protein Test Volume and Germany, Serotonin Test Volume and Germany, Sialic Acid Test Volume and Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment Germany, TDT Test Volume and Diagnostics

Germany, Thymidine Kinase Test Volume and Germany, Thyroglobulin Test Volume and Germany, TPA Test Volume and Diagnostics Germany, Total Cancer Diagnostics Sales By Major Supplier Germany, AFP Testing Market Diagnostics Sales by Major Supplier Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier Germany, CEA Testing Market Diagnostics Sales by Major Supplier Germany, PSA Testing Market Diagnostics Sales by Major Supplier